Immunotherapy with Bet v 1 derived contiguous overlapping peptides: results of a phase I/IIa clinical trial in birch pollen allergic volunteers

被引：0
|
作者：
Spertini, F. [1 ]
Perrin, Y. [1 ]
Longaretti, Pellaton C. [1 ]
Barbier, N. [1 ]
Thierry, A. [1 ]
Audran, R. [1 ]
Charlon, V [2 ]
Reymond, C. [2 ]
机构：
[1] CHU Vaudois, Div Immunol & Allergy, Lausanne, Switzerland
[2] Anergis SA, Epalinges, Switzerland
来源：
ALLERGY | 2010年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
8
引用
收藏
页码：4 / 4
页数：1
相关论文
共 38 条
  • [1] Safety and immunogenicity of immunotherapy with Bet v 1-derived contiguous overlapping peptides
    Spertini, Francois
    Perrin, Yannick
    Audran, Regine
    Pellaton, Celine
    Boudousquie, Caroline
    Barbier, Nathalie
    Thierry, Anne-Christine
    Charlon, Vincent
    Reymond, Christophe
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 134 (01) : 239 - U801
  • [2] Immunotherapy with Bet v 1 derived contiguous overlapping peptides leads to long term immunoregulatory responses
    Spertini, F.
    Barbier, N.
    Thierry, A.
    Audran, R.
    Charlon, V
    Reymond, C.
    ALLERGY, 2011, 66 : 102 - 102
  • [3] Efficacy of 2 months of allergen-specific immunotherapy with Bet v 1-derived contiguous overlapping peptides in patients with allergic rhinoconjunctivitis: Results of a phase IIb study
    Spertini, Francois
    DellaCorte, Gilles
    Kettner, Alexander
    de Blay, Frederic
    Jacobsen, Lars
    Jutel, Marek
    Worm, Margitta
    Charlon, Vincent
    Reymond, Christophe
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 138 (01) : 162 - 168
  • [4] Immunotherapy with Bet v 1 derived contiguous overlapping peptides leads to long-term immunoregulatory responses
    Spertini, F.
    Barbier, N.
    Thierry, A. C.
    Audran, R.
    Charlon, V.
    Reymond, C.
    ALLERGOLOGIE, 2011, 34 (02) : 86 - 87
  • [5] Immunotherapy with Bet v 1-derived contiguous overlapping peptides leads to long term immunoregulatory responses
    Spertini, Francois
    Barbier, Nathalie
    Thierry, Anne-Christine
    Regine, Audran
    Charlon, Vincent
    Reymond, Christophe
    JOURNAL OF IMMUNOLOGY, 2011, 186
  • [6] Clinical effects of immunotherapy with genetically modified recombinant birch pollen Bet v 1 derivatives
    Purohit, A.
    Niederberger, V.
    Kronqvist, M.
    Horak, F.
    Gronneberg, R.
    Suck, R.
    Weber, B.
    Fiebig, H.
    van Hage, M.
    Pauli, G.
    Valenta, R.
    Cromwell, O.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2008, 38 (09): : 1514 - 1525
  • [7] Preventive Administration of Non-Allergenic Bet v 1 Peptides Reduces Allergic Sensitization to Major Birch Pollen Allergen, Bet v 1
    Akinfenwa, Oluwatoyin
    Huang, Huey-Jy
    Linhart, Birgit
    Focke-Tejkl, Margarete
    Vrtala, Susanne
    Poroshina, Alina
    Nikonova, Alexandra
    Khaitov, Musa
    Campion, Nicholas J.
    Eckl-Dorna, Julia
    Niederberger-Leppin, Verena
    Kratzer, Bernhard
    Tauber, Peter Anton
    Pickl, Winfried F.
    Kundi, Michael
    Campana, Raffaela
    Valenta, Rudolf
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [8] Bet v 1-specific immune response in birch pollen allergic patients treated with sublingual immunotherapy
    Moebs, C.
    Ruge, K.
    Hertl, M.
    Pfuetzner, W.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2012, 132 : S4 - S4
  • [9] Clinical efficacy of subcutaneous immunotherapy in birch pollen allergic patients: a randomized, double-blind, placebo-controlled study with recombinant Bet v 1 versus natural Bet v 1 or standardized birch extract
    Pauli, G.
    Malling, H. -J.
    Rak, S.
    Horak, F.
    Pastorello, E. A.
    Purohit, A.
    Larsen, T. H.
    Arvidsson, M.
    Kavina, A.
    Szaal, S.
    Schroeder, J.
    Vighi, G.
    Galvain, S.
    Andre, C.
    Melac, M.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2006, 36 (09): : 1206 - 1206
  • [10] Bet v 1 derived contiguous overlapping peptides activate human B- and T Cell responses in human
    Kettner, A.
    Reymond, C.
    Duc, S.
    Boand, V
    Thierry, A. C.
    Audran, R.
    Spertini, F.
    ALLERGY, 2016, 71 : 506 - 506
1234